About Us

Jim Cramer Tries To Limit Risk On Ionis Pharmaceuticals And Sarepta Therapeutics

By: via Benzinga
Jim Cramer said on CNBC's Mad Money that he doesn't want to recommend speculative stocks as Ionis Pharmaceuticals Inc ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.